# Progress Note 05 — Sick Visit

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Phillis Wheatley (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-EN015-SYN-TD
- Date: 1773-09-21
- Fictional facility: St. Posthumous Health Center
- Fictional author: Abena Hartley-Okonkwo, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Sick Visit
- Services: Problem-oriented office visit, established patient, with bronchodilator treatment and reassessment in clinic

## Chief complaint

Wheeze and tight chest for three days with a cold, a week after returning from abroad. **S**

## History of present illness

Miss Wheatley returned from abroad eight days ago. She was well all summer: she used her reliever only two or three times a month, never needed the standby prednisone, and feels the time away did her good. Five days ago, in the first cold, damp days after her return, she caught a cold with a sore throat and runny nose. For three days her chest has been tight and wheezy; she woke twice last night and has used six to eight extra inhalations of budesonide-formoterol on each of the last two days, as her action plan allows. This morning her peak flow was 280 L/min, in the yellow zone, and she called the clinic. She can speak in full sentences and has no chest pain or green sputum. She has been very busy since her return and is anxious not to lose time. **S**

| Element | Detail |
|---|---|
| Onset | Cold five days ago; asthma worse for three days |
| Severity | Woke twice last night; six to eight reliever inhalations a day; peak flow 280 L/min this morning |
| Context | As-needed budesonide-formoterol (GINA track 1, step 2); yellow zone of her action plan |
| Associated signs and symptoms | Sore throat and runny nose; temperature 37.6 °C; no chest pain or purulent sputum |
| Risk history | No previous exacerbation needing oral corticosteroids, emergency care or admission |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Tired; low-grade temperature; no rigors |
| Respiratory | Positive | Wheeze, chest tightness, dry cough and night waking; no hemoptysis |
| Ears, nose, mouth, and throat | Positive | Sore throat and clear nasal discharge |
| Cardiovascular | Negative | No chest pain or palpitations |

4 systems reviewed. **S**

## Current medications

- Prednisone 20 mg oral tablet, standby course for the sea journey and the summer away: two tablets (40 mg) each morning for five days, to start only as her action plan directs **S**
- Folic acid 0.4 mg oral tablet, one tablet daily **S**
- Budesonide-formoterol 160/4.5 mcg inhaler as maintenance and reliever (GINA track 1, step 3): one inhalation twice daily and one inhalation as needed, no more than 12 inhalations a day **S**

## Allergies

- No known allergy **S**

## Objective

BP 108/68 mmHg; pulse 98 bpm; respirations 20/min; temperature 37.6 °C; oxygen saturation 96% on room air; weight 47.2 kg; BMI 20.4 kg/m². All vital signs are synthetic.

Peak expiratory flow: 270 L/min (low). All results are synthetic.

## Physical examination

| System | Finding |
|---|---|
| General | Alert, sitting upright, speaking in full sentences; no accessory muscle use |
| Vital signs | Pulse 98, respiratory rate 20, oxygen saturation 96 percent on room air, temperature 37.6 °C; peak flow 270 L/min (68 percent of her best) |
| Head, eyes, ears, nose, and throat | Red throat without exudate; clear nasal discharge; no sinus tenderness |
| Respiratory | Scattered expiratory wheeze with good air entry; no crackles |
| Reassessment after 30 minutes | After two inhalations of budesonide-formoterol with a spacer: peak flow 330 L/min (82 percent), wheeze much reduced, pulse 90, respiratory rate 16 |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Asthma exacerbation with a cold** (J45.31). A mild-to-moderate exacerbation triggered by a viral cold: peak flow 68 percent of her best, rising to 82 percent after treatment, with normal oxygen saturation. Rapid influenza and COVID-19 tests are negative. She does not need an oral corticosteroid now, because she responded well and her peak flow is above 60 percent; no antibiotic, because there is no sign of bacterial infection. **S**
   - Step up to maintenance and reliever: budesonide-formoterol one inhalation twice daily and one as needed, up to 12 a day, through the winter.
   - Standby prednisone 40 mg daily for five days only if peak flow falls below 240 L/min or does not improve within 48 hours, with a call to the clinic.
   - Emergency care or 911 if peak flow falls below 160 L/min, she cannot speak in sentences, or the reliever does not help.
   - Nurse telephone call in two days; clinic review within a week.
2. **Asthma** (J45.30). Cold, damp weather and a cold are her main triggers, as they were last winter. **S**
   - Influenza and COVID-19 vaccines for the new season at the review, once the cold has passed.

## Medication changes

- Stopped: Budesonide-formoterol 160/4.5 mcg inhaler as needed only (GINA track 1, step 2, anti-inflammatory reliever): one inhalation whenever needed for symptoms or before exercise in the cold, no more than 12 inhalations a day **S**
- Stopped: Meclizine 25 mg oral tablet, one tablet an hour before sailing and then once daily as needed for seasickness **S**
- Started: Budesonide-formoterol 160/4.5 mcg inhaler as maintenance and reliever (GINA track 1, step 3): one inhalation twice daily and one inhalation as needed, no more than 12 inhalations a day **S**

## Guideline basis

- Global Strategy for Asthma Management and Prevention, 2025 update (2025), Global Initiative for Asthma
- 2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group (2020), National Heart, Lung, and Blood Institute (J Allergy Clin Immunol 2020;146(6):1217-1270)

## Follow-up

- Nurse telephone call in two days. Clinic review within a week. Emergency care for any red-zone sign. **S**
- Next scheduled visit 1773-10-26: asthma review after an exacerbation with a cold on her return from abroad: control, repeat spirometry and FeNO, the winter plan, completion of vaccines, and her changed circumstances. **S**
